Tudor Investment Corp’s Niagen Bioscience NAGE Stock Holding History

Tudor Investment Corp’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+86,059	New	+$349K	﹤0.01%	3174
2026 Q1	–	Sell	-56,536	Closed	-$360K	–	4420
2025 Q4	$360K	Buy	+56,536	New	+$393K	﹤0.01%	2933
2025 Q3	–	Sell	-159,548	Closed	-$2.3M	–	4011
2025 Q2	$2.3M	Sell	159,548 -212,250	-57%	-$2.1M	0.01%	1566
2025 Q1	$2.57M	Buy	371,798 +154,230	+71%	+$969K	0.01%	1174
2024 Q4	$1.15M	Buy	+217,568	New	+$1.19M	﹤0.01%	1633

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tudor Investment Corp's NAGE Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Niagen Bioscience (NAGE) in Q2 2026: 86,059 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #3174 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in NAGE as recently as Q4 2025.

Tudor Investment Corp first reported a position in NAGE in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.57M in Q1 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Tudor Investment Corp held 86,059 shares of Niagen Bioscience worth $275K as of Q2 2026.
Niagen Bioscience was a new Tudor Investment Corp position in Q2 2026.
Niagen Bioscience made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #3174 holding.
Tudor Investment Corp first reported a position in Niagen Bioscience in Q4 2024 and has held it in 5 quarters since.
Tudor Investment Corp's Niagen Bioscience position peaked at $2.57M in Q1 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.